Credit Suisse’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-350
| Closed | -$9.42K | – | 3274 |
|
|
2023
Q1 | $9.42K | Hold |
350
| – | – | ﹤0.01% | 3240 |
|
|
2022
Q4 | $12.4K | Sell |
350
-8
| -2% | -$283 | ﹤0.01% | 3483 |
|
|
2022
Q3 | $81K | Buy |
358
+6
| +2% | +$1.36K | ﹤0.01% | 3459 |
|
|
2022
Q2 | $66K | Buy |
+352
| New | +$66K | ﹤0.01% | 3581 |
|
|
2021
Q1 | – | Sell |
-4,616
| Closed | -$1.7M | – | 3608 |
|
|
2020
Q4 | $1.7M | Buy |
4,616
+318
| +7% | +$117K | ﹤0.01% | 2226 |
|
|
2020
Q3 | $1.05M | Sell |
4,298
-62
| -1% | -$15.1K | ﹤0.01% | 2232 |
|
|
2020
Q2 | $1.26M | Buy |
4,360
+593
| +16% | +$171K | ﹤0.01% | 2181 |
|
|
2020
Q1 | $768K | Buy |
3,767
+615
| +20% | +$125K | ﹤0.01% | 2294 |
|
|
2019
Q4 | $1.41M | Sell |
3,152
-1,368
| -30% | -$612K | ﹤0.01% | 2301 |
|
|
2019
Q3 | $1.39M | Buy |
+4,520
| New | +$1.39M | ﹤0.01% | 2181 |
|
|
2015
Q3 | – | Sell |
-55
| Closed | -$31K | – | 4183 |
|
|
2015
Q2 | $31K | Sell |
55
-186
| -77% | -$105K | ﹤0.01% | 4188 |
|
|
2015
Q1 | $2.06M | Buy |
241
+64
| +36% | +$547K | ﹤0.01% | 2145 |
|
|
2014
Q4 | $1.56M | Buy |
177
+94
| +113% | +$827K | ﹤0.01% | 2437 |
|
|
2014
Q3 | $389K | Buy |
83
+58
| +232% | +$272K | ﹤0.01% | 3412 |
|
|
2014
Q2 | $180K | Buy |
+25
| New | +$180K | ﹤0.01% | 3980 |
|